677702-36-2Relevant articles and documents
Synthesis, antitumor evaluation, and molecular docking studies of indole–indazolyl hydrazide–hydrazone derivatives
Sreenivasulu, Reddymasu,Sujitha, Pombala,Jadav, Surender Singh,Ahsan, Mohamed Jawed,Kumar, C. Ganesh,Raju, Rudraraju Ramesh
, p. 305 - 314 (2017)
Abstract: A series of ten novel hydrazide–hydrazones linked indole and indazole moieties were designed and synthesized. All the synthesized compounds were evaluated for their cytotoxicity against four human cancer cell lines (HeLa, MDA-MB-231, MCF-7, and A549). Three of the synthesized compounds showed promising cytotoxicity specifically on some of the tested cell lines with IC50 values ranging between 1.93 and 25.6?μM. Further, one compound was identified as a promising drug lead which showed promising cytotoxicity with IC50 value of 1.93?μM towards MCF-7 breast cancer cell line as compared to the standard drug doxorubicin (IC50 value 0.98?μM). While, all these new compounds showed no cytotoxicity on the normal human embryonic kidney cell line, HEK-293. Graphical abstract: [Figure not available: see fulltext.]
Synthesis and anticancer evaluation of indazole-aryl hydrazide-hydrazone derivatives
Rudavath, Durgesh,Sreenivasulu, Reddymasu,Pinapati, Srinivasa Rao,Raju, Rudraraju Ramesh
, p. 433 - 438 (2020/06/29)
A new series of hydrazide-hydrazones linked between indazole and substituted benzaldehydes were designed, synthesized and evaluated for their cytotoxicity against four human cancer cell lines (HeLa, MDA-MB-231, MCF-7 and A549). Among the synthesized compo